)
Nektar Therapeutics (NKTR) investor relations material
Nektar Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 4, 2026, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials and vote by June 3, 2026.
Voting matters and shareholder proposals
Election of Howard W. Robin as director is up for shareholder vote, with board recommending approval.
Proposal to amend the 2017 Performance Incentive Plan to add 3,000,000 shares for issuance.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Advisory vote on executive compensation (say-on-pay) included, with board recommending approval.
Board of directors and corporate governance
Board recommends approval of all proposals presented for shareholder vote.
- Proxy covers director election, equity plan amendment, auditor ratification, and say-on-pay.NKTR
Proxy filing24 Apr 2026 - Rezpegaldesleukin showed durable efficacy and strong safety at 52 weeks, supporting first-line use.NKTR
Study update20 Apr 2026 - Phase 2 success and major financing drive phase 3 launch for lead immunology candidate.NKTR
Q4 202512 Mar 2026 - REZPEG demonstrates durable efficacy and safety, setting new standards in immune-mediated diseases.NKTR
TD Cowen 46th Annual Health Care Conference4 Mar 2026 - Durable efficacy and deepening responses maintained with strong safety over 52 weeks.NKTR
Study result10 Feb 2026 - REZPEG shows strong efficacy in atopic dermatitis, with pivotal data expected in early 2025.NKTR
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Phase 2b data for Rezpeg in atopic dermatitis and alopecia areata expected in 2025.NKTR
Jefferies 2024 Global Healthcare Conference1 Feb 2026 - Revenue up, net loss narrowed, and strong cash reserves support advancing clinical pipeline.NKTR
Q2 20241 Feb 2026 - Phase IIb trials for REZPEG in atopic dermatitis and alopecia areata target 2025 data readouts.NKTR
H.C. Wainwright 26th Annual Global Investment Conference 202421 Jan 2026
Next Nektar Therapeutics earnings date
Next Nektar Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage